Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Secukinumab in plaque psoriasis--results of two phase 3 trials.
- R. Langley, B. Elewski, C. Papavassilis
- MedicineThe New England journal of medicine
- 23 July 2014
TLDR
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.
- M. Lebwohl, B. Strober, A. Nirula
- Medicine, BiologyThe New England journal of medicine
- 30 September 2015
TLDR
Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment.
- R. Langley, C. Ellis
- MedicineJournal of the American Academy of Dermatology
- 1 October 2004
Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study.
- K. Gordon, R. Langley, M. Okun
- MedicineJournal of the American Academy of Dermatology
- 1 October 2006
A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis.
- K. Reich, R. Langley, J. Valdes
- MedicineThe New England journal of medicine
- 26 October 2011
TLDR
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- K. Papp, R. Langley, K. Reich
- MedicineThe Lancet
- 23 May 2008
Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey.
- M. Lebwohl, H. Bachelez, P. C. van de Kerkhof
- MedicineJournal of the American Academy of Dermatology
- 1 May 2014
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
- S. Tyring, K. Gordon, A. Jahreis
- MedicineArchives of dermatology
- 1 June 2007
TLDR
...
...